(AIG) American International - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0268747849
Stock:
Total Rating 39
Risk 86
Buy Signal 0.64
| Risk 5d forecast | |
|---|---|
| Volatility | 21.5% |
| Relative Tail Risk | -4.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.11 |
| Alpha | -6.25 |
| Character TTM | |
|---|---|
| Beta | 0.476 |
| Beta Downside | 0.750 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.12% |
| CAGR/Max DD | 0.55 |
EPS (Earnings per Share)
Revenue
Description: AIG American International
American International Group, Inc. provides insurance products for commercial, institutional, and individual customers in North America and internationally. It operates through three segments: North America Commercial, International Commercial, and Global Personal. The company offers commercial and industrial property insurance, including business interruption and package insurance that cover exposure to made and natural disasters; general liability, environmental, commercial automobile liability, workers' compensation, excess casualty, and crisis management insurance products; risk-sharing and other customized structured programs for large corporate and multinational customers; professional liability insurance; and marine, energy-related property insurance products, aviation, political risk, trade credit, and trade finance products. It also provides group personal accident and business travel products for employees, associations, and other organizations; voluntary and sponsor-paid personal accident and supplemental health products for individuals; and personal auto and homeowners in selected markets, comprehensive extended warranty, device protection insurance, home warranty and related services, and insurance for high net-worth individuals. In addition, the company offers mortgage and other loans receivable, such as commercial mortgages, life insurance policy loans, commercial loans, and other loans and notes receivable. American International Group, Inc. was founded in 1919 and is headquartered in New York, New York.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 3.10b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.03 > 1.0 |
| NWC/Revenue: 51.34% < 20% (prev -3.09%; Δ 54.43% < -1%) |
| CFO/TA 0.04 > 3% & CFO 5.99b > Net Income 3.10b |
| Net Debt (7.76b) to EBITDA (7.73b): 1.00 < 3 |
| Current Ratio: 9.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (546.4m) vs 12m ago -12.90% < -2% |
| Gross Margin: 34.51% > 18% (prev 0.30%; Δ 3422 % > 0.5%) |
| Asset Turnover: 16.60% > 50% (prev 16.90%; Δ -0.30% > 0%) |
| Interest Coverage Ratio: 10.80 > 6 (EBITDA TTM 7.73b / Interest Expense TTM 396.0m) |
Altman Z'' 1.81
| A: 0.09 (Total Current Assets 15.30b - Total Current Liabilities 1.56b) / Total Assets 161.25b |
| B: 0.23 (Retained Earnings 37.19b / Total Assets 161.25b) |
| C: 0.03 (EBIT TTM 4.28b / Avg Total Assets 161.29b) |
| D: 0.31 (Book Value of Equity 36.97b / Total Liabilities 120.09b) |
| Altman-Z'' Score: 1.81 = BBB |
Beneish M -3.70
| DSRI: 0.28 (Receivables 2.89b/10.46b, Revenue 26.77b/27.27b) |
| GMI: 0.86 (GM 34.51% / 29.61%) |
| AQI: 1.13 (AQ_t 0.90 / AQ_t-1 0.80) |
| SGI: 0.98 (Revenue 26.77b / 27.27b) |
| TATA: -0.02 (NI 3.10b - CFO 5.99b) / TA 161.25b) |
| Beneish M-Score: -3.70 (Cap -4..+1) = AAA |
What is the price of AIG shares?
As of February 26, 2026, the stock is trading at USD 80.15 with a total of 1,852,546 shares traded.
Over the past week, the price has changed by +0.45%, over one month by +8.62%, over three months by +7.41% and over the past year by +3.60%.
Over the past week, the price has changed by +0.45%, over one month by +8.62%, over three months by +7.41% and over the past year by +3.60%.
Is AIG a buy, sell or hold?
American International has received a consensus analysts rating of 3.76.
Therefor, it is recommend to hold AIG.
- StrongBuy: 5
- Buy: 3
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AIG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 87.1 | 8.7% |
| Analysts Target Price | 87.1 | 8.7% |
AIG Fundamental Data Overview February 20, 2026
P/E Trailing = 14.6483
P/E Forward = 10.2775
P/S = 1.6128
P/B = 1.0374
P/EG = 0.8547
Revenue TTM = 26.77b USD
EBIT TTM = 4.28b USD
EBITDA TTM = 7.73b USD
Long Term Debt = 9.19b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 9.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.76b USD (from netDebt column, last quarter)
Enterprise Value = 39.54b USD (42.92b + Debt 9.04b - CCE 12.41b)
Interest Coverage Ratio = 10.80 (Ebit TTM 4.28b / Interest Expense TTM 396.0m)
EV/FCF = 11.93x (Enterprise Value 39.54b / FCF TTM 3.31b)
FCF Yield = 8.38% (FCF TTM 3.31b / Enterprise Value 39.54b)
FCF Margin = 12.38% (FCF TTM 3.31b / Revenue TTM 26.77b)
Net Margin = 11.56% (Net Income TTM 3.10b / Revenue TTM 26.77b)
Gross Margin = 34.51% ((Revenue TTM 26.77b - Cost of Revenue TTM 17.53b) / Revenue TTM)
Gross Margin QoQ = 33.92% (prev 33.76%)
Tobins Q-Ratio = 0.25 (Enterprise Value 39.54b / Total Assets 161.25b)
Interest Expense / Debt = 1.16% (Interest Expense 105.0m / Debt 9.04b)
Taxrate = 20.16% (782.0m / 3.88b)
NOPAT = 3.41b (EBIT 4.28b * (1 - 20.16%))
Current Ratio = 9.83 (Total Current Assets 15.30b / Total Current Liabilities 1.56b)
Debt / Equity = 0.22 (Debt 9.04b / totalStockholderEquity, last quarter 41.14b)
Debt / EBITDA = 1.00 (Net Debt 7.76b / EBITDA 7.73b)
Debt / FCF = 2.34 (Net Debt 7.76b / FCF TTM 3.31b)
Total Stockholder Equity = 41.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.92% (Net Income 3.10b / Total Assets 161.25b)
RoE = 7.50% (Net Income TTM 3.10b / Total Stockholder Equity 41.29b)
RoCE = 8.47% (EBIT 4.28b / Capital Employed (Equity 41.29b + L.T.Debt 9.19b))
RoIC = 6.77% (NOPAT 3.41b / Invested Capital 50.40b)
WACC = 6.50% (E(42.92b)/V(51.95b) * Re(7.67%) + D(9.04b)/V(51.95b) * Rd(1.16%) * (1-Tc(0.20)))
Discount Rate = 7.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -12.15%
[DCF] Terminal Value 82.57% ; FCFF base≈3.30b ; Y1≈2.96b ; Y5≈2.53b
[DCF] Fair Price = 104.7 (EV 63.93b - Net Debt 7.76b = Equity 56.17b / Shares 536.6m; r=6.50% [WACC]; 5y FCF grow -12.62% → 2.90% )
EPS Correlation: -23.50 | EPS CAGR: -22.71% | SUE: 0.28 | # QB: 0
Revenue Correlation: -87.32 | Revenue CAGR: -19.76% | SUE: -0.12 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.93 | Chg7d=-0.019 | Chg30d=-0.005 | Revisions Net=-3 | Analysts=18
EPS current Year (2026-12-31): EPS=7.86 | Chg7d=+0.019 | Chg30d=+0.012 | Revisions Net=+4 | Growth EPS=+10.8% | Growth Revenue=+8.8%
EPS next Year (2027-12-31): EPS=8.85 | Chg7d=+0.105 | Chg30d=+0.125 | Revisions Net=+6 | Growth EPS=+12.6% | Growth Revenue=+7.4%
[Analyst] Revisions Ratio: -0.33 (3 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.1% (Discount Rate 7.9% - Earnings Yield 6.8%)
[Growth] Growth Spread = +2.6% (Analyst 3.7% - Implied 1.1%)
P/E Forward = 10.2775
P/S = 1.6128
P/B = 1.0374
P/EG = 0.8547
Revenue TTM = 26.77b USD
EBIT TTM = 4.28b USD
EBITDA TTM = 7.73b USD
Long Term Debt = 9.19b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 9.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.76b USD (from netDebt column, last quarter)
Enterprise Value = 39.54b USD (42.92b + Debt 9.04b - CCE 12.41b)
Interest Coverage Ratio = 10.80 (Ebit TTM 4.28b / Interest Expense TTM 396.0m)
EV/FCF = 11.93x (Enterprise Value 39.54b / FCF TTM 3.31b)
FCF Yield = 8.38% (FCF TTM 3.31b / Enterprise Value 39.54b)
FCF Margin = 12.38% (FCF TTM 3.31b / Revenue TTM 26.77b)
Net Margin = 11.56% (Net Income TTM 3.10b / Revenue TTM 26.77b)
Gross Margin = 34.51% ((Revenue TTM 26.77b - Cost of Revenue TTM 17.53b) / Revenue TTM)
Gross Margin QoQ = 33.92% (prev 33.76%)
Tobins Q-Ratio = 0.25 (Enterprise Value 39.54b / Total Assets 161.25b)
Interest Expense / Debt = 1.16% (Interest Expense 105.0m / Debt 9.04b)
Taxrate = 20.16% (782.0m / 3.88b)
NOPAT = 3.41b (EBIT 4.28b * (1 - 20.16%))
Current Ratio = 9.83 (Total Current Assets 15.30b / Total Current Liabilities 1.56b)
Debt / Equity = 0.22 (Debt 9.04b / totalStockholderEquity, last quarter 41.14b)
Debt / EBITDA = 1.00 (Net Debt 7.76b / EBITDA 7.73b)
Debt / FCF = 2.34 (Net Debt 7.76b / FCF TTM 3.31b)
Total Stockholder Equity = 41.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.92% (Net Income 3.10b / Total Assets 161.25b)
RoE = 7.50% (Net Income TTM 3.10b / Total Stockholder Equity 41.29b)
RoCE = 8.47% (EBIT 4.28b / Capital Employed (Equity 41.29b + L.T.Debt 9.19b))
RoIC = 6.77% (NOPAT 3.41b / Invested Capital 50.40b)
WACC = 6.50% (E(42.92b)/V(51.95b) * Re(7.67%) + D(9.04b)/V(51.95b) * Rd(1.16%) * (1-Tc(0.20)))
Discount Rate = 7.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -12.15%
[DCF] Terminal Value 82.57% ; FCFF base≈3.30b ; Y1≈2.96b ; Y5≈2.53b
[DCF] Fair Price = 104.7 (EV 63.93b - Net Debt 7.76b = Equity 56.17b / Shares 536.6m; r=6.50% [WACC]; 5y FCF grow -12.62% → 2.90% )
EPS Correlation: -23.50 | EPS CAGR: -22.71% | SUE: 0.28 | # QB: 0
Revenue Correlation: -87.32 | Revenue CAGR: -19.76% | SUE: -0.12 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.93 | Chg7d=-0.019 | Chg30d=-0.005 | Revisions Net=-3 | Analysts=18
EPS current Year (2026-12-31): EPS=7.86 | Chg7d=+0.019 | Chg30d=+0.012 | Revisions Net=+4 | Growth EPS=+10.8% | Growth Revenue=+8.8%
EPS next Year (2027-12-31): EPS=8.85 | Chg7d=+0.105 | Chg30d=+0.125 | Revisions Net=+6 | Growth EPS=+12.6% | Growth Revenue=+7.4%
[Analyst] Revisions Ratio: -0.33 (3 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.1% (Discount Rate 7.9% - Earnings Yield 6.8%)
[Growth] Growth Spread = +2.6% (Analyst 3.7% - Implied 1.1%)